Skip to main content
Have a personal or library account? Click to login
Solid lipid based nanocarriers: An overview / Nanonosači na bazi čvrstih lipida: Pregled Cover

Solid lipid based nanocarriers: An overview / Nanonosači na bazi čvrstih lipida: Pregled

Acta Pharmaceutica
Volume 62 (2012): Issue 4 (December 2012)
By: ,  ,  ,  ,  ,   and    
Open Access
|Jan 2013
References

References

  1. 1. C. V. Pardeshi, P. V. Rajput, V. S. Belgamwar and A. R. Tekade, Formulation, optimization and evaluation of spray-dried mucoadhesive microspheres as intranasal carriers for valsartan,(2011) 103-114; DOI: 10.3109/02652048.2011.630106.
    Open DOISearch in Google Scholar
  2. 2. W. Mehnert and K. Mader, Solid lipid nanoparticles: Production, characterization and applications,.(2001) 165-196; DOI: 10.1016/S0169-409X(01)00105-3.
    Open DOISearch in Google Scholar
  3. 3. S. Mukherjee, S. Ray and R. S. Thakur, Solid lipid nanoparticles: A modern formulation approach in drug delivery system,(2009) 349-358.
    Search in Google Scholar
  4. 4. R. H. Müller, K. Mäder and S. Gohla, Solid lipid nanoparticles (SLN) for controlled drug delivery - A review of the state of the art,(2000) 161-177.
    Open DOISearch in Google Scholar
  5. 5. R. H. Müller, M. Radtke and S. A. Wissing, Nanostructured lipid matrices for improved microencapsulation of drugs,(2002) 121-128; DOI: 10.1016/S0378-5173(02)00180-1.
    Open DOISearch in Google Scholar
  6. 6. R. H. Müller, M. Radtke and S. A. Wissing, Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations,(Suppl. 1) (2002) S131-S155; DOI: 10.1016/S0169-409X(02)00118-7.
    Open DOISearch in Google Scholar
  7. 7. R. H. Müller, R. D. Petersen, A. Hommoss and J. Pardeike, Nanostructured lipid carriers (NLC) for cosmetic dermal products,(2007) 522-530; DOI: 10.1016/j.addr.2007.04.012.
    Open DOISearch in Google Scholar
  8. 8. J. Y. Fang, C. L. Fang, C. H. Liu and Y. H. Su, Lipid nanoparticles as vehicles for psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers,(2008) 633-640; DOI: 10.1016/j.ejpb.2008.05.008.
    Open DOISearch in Google Scholar
  9. 9. E. B. Souto, S. A. Wissing, C. M. Barbosa and R. H. Müller, Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery,(2004) 71-77; DOI: 10.1016/j.ijpharm.2004.02.032.
    Open DOISearch in Google Scholar
  10. 10. M. Joshi and V. Patravale, Nanostructured lipid carriers (NLC) based gel of celecoxib,(2008) 124-132; DOI: 10.1016/j.ijpharm.2007.05.060.
    Open DOISearch in Google Scholar
  11. 11. V. Teeranachaideekul, R. H. Müller and V. B. Junyaprasert, Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC) - Effect of formulation parameters on physicochemical stability,(2007) 198-206; DOI: 10.1016/j.ijpharm.2007.03.022.
    Open DOISearch in Google Scholar
  12. 12. S. Doktorovova, J. Araujo, M. L. Garcia, E. Rakovsky and E. B. Souto, Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC),(2010) 538-542; DOI: 10.1016/j.colsurfb.2009.09.033.
    Open DOISearch in Google Scholar
  13. 13. C. Olbrich, A. Gessner, W. Schroder, O. Kayser and R. H. Müller, Lipid-drug conjugate of the hydrophilic drug diminazine-cytotoxicity testing and mouse serum adsorption,(2004) 425-435; DOI: 10.1016/j.jconrel.2004.02.024.
    Open DOISearch in Google Scholar
  14. 14. H. L. Wong, A. M. Rauth, R. Bendayan and X. Y. Wu, In-vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model,(2007) 300-308; DOI: 10.1016/j.ejpb.2006.10.022.
    Open DOISearch in Google Scholar
  15. 15. H. L. Wong, A. M. Rauth, R. Bendayan and X. Y. Wu, Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment for multidrug-resistant breast cancer,(2006) 275-284; DOI: 10.1016/j.jconrel.2006.09.007.
    Open DOISearch in Google Scholar
  16. 16. L. Zhang, J. M. Chan, F. X. Gu, A. Z. Wang, A. F. Radovic-Moreno, F. Alexis, R. Langer and O. C. Farokhzad, Self-assembled lipid-polymer hybrid nanoparticles: A robust drug delivery platform,(2008) 1696-1702; DOI: 10.1021/nn800275r.
    Open DOISearch in Google Scholar
  17. 17. Y. Li, H. L. Wong, A. J. Shuhendler, A. M. Rauth and X. Y. Wu, Molecular interactions, internal structure and drug release kinetics of rationally developed polymer-lipid hybrid nanoparticles,(2008) 60-70; DOI: 10.1016/j.jconrel.2008.02.014.
    Open DOISearch in Google Scholar
  18. 18. C. Salvador-Morales, L. Zhang, R. Langer and O. C. Farokhzad, Immunocompatibility properties of polymer-lipid hybrid nanoparticles with heterogeneous surface functional groups,(2009) 2231-2240; DOI: 10.1016/j.biomaterials.2009.01.005.
    Open DOISearch in Google Scholar
  19. 19. R. Lander, W. Manger, M. Scouloudis, A. Ku, C. Davis and A. Lee, Gaulin homogenization: a mechanistic study,(2000) 80-85; DOI: 10.1021/bp990135c.
    Open DOISearch in Google Scholar
  20. 20. R. H. Müller, S. Benita and B. Bohm, Emulsions and nanosuspensions for the formulation of poorly soluble drugs,(2001) 143-144.
    Open DOISearch in Google Scholar
  21. 21. B. Siekmann and K. Westesen, Solid lipid nanoparticles stabilized by tyloxapol,(1994) 117-194; DOI: 10.1016/0928-0987(94)90407-3.
    Open DOISearch in Google Scholar
  22. 22. H. Bunjes, B. Siekmann and K. Westesen,, in, Ed. S. Benita, Hardwood Academic Publishers, Amsterdam 1998, pp. 175-204.
    Open DOISearch in Google Scholar
  23. 23. V. Venkateswarlu and K. Manjunath, Preparation, characterization and in-vitro release kinetics of clozapine solid lipid nanoparticles,(2004) 627-638; DOI: 10.1016/j.jconrel.2004.01.005.
    Open DOISearch in Google Scholar
  24. 24. S. Gande, V. Vobalaboina, M. Kopparam, V. Venkateswarlu and S. Vemula, Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles,(2007) E1-E9.
    Open DOISearch in Google Scholar
  25. 25. S. P. Vyas and R. K. Khar,, 1st ed., CBS Publishers and Distributors, New Delhi 2002, pp. 346-348.
    Search in Google Scholar
  26. 26. S. Xie, L. Zhu, Z. Dong, X. Wang, Y. Wang, X. Li and W. Zhou, Preparation, characterization and pharmacokinetics of enrofloxacin loaded solid lipid nanoparticles: Influences of fatty acids,(2011) 382-387; DOI: 10.1016/j.colsurfb.2010.12.014; DOI: 10.1016/j.colsurfb.2010.12.014.
    Search in Google Scholar
  27. 27. A. V. Heydenreich, R. Westmeier, N. Pedersen, H. S. Poulsen and H. G. Kristensen, Preparation and purification of cationic solid lipid nanospheres-effects on particle size, physical stability and cell toxicity,(2003) 83-87; DOI: 10.1016/S0378-5173(02)00688-9.
    Open DOISearch in Google Scholar
  28. 28. N. K. Jain,, 1ed., CBS Publishers and Distributors, New Delhi 2001, pp. 418-424.
    Search in Google Scholar
  29. 29. H. Zhou, T. Gu, D. Yang, Z. Jiang and J. Zeng, Griseofulvin solid lipid nanoparticles based on microemulsion technique,(2011) 47-50; DOI: 10.4028/www.scientific.net/AMR.197-198.47.
    Open DOISearch in Google Scholar
  30. 30. M. R. Gasco and L. P. AntonelliUS Pat. 5,250,236, 05 Oct. 1993.
    Search in Google Scholar
  31. 31. S. Morel, M. R. Gasco and R. Cavalli, Incorporation in lipospheres of [D-Trp-6]LHRH,(1994) RI-R3; DOI: 10.1016/0378-5173(94)90466-9.
    Open DOISearch in Google Scholar
  32. 32. S. Morel, E. Ugazio, R. Cavalli and M. R. Gasco, Thymopentin in solid lipid nanoparticles,(1996) 259-261; DOI: 10.1016/0378-5173(95)04388-8.
    Open DOISearch in Google Scholar
  33. 33. T. Hammady, A. El-Gindy, E. Lejmi, R. S. Dhanikula, P. Moreau and P. Hildgen, Characteristics and properties of nanospheres co-loaded with lipophilic and hydrophilic drug models,(2009) 185-195; DOI: 10.1016/j.ijpharm.2008.10.034.
    Open DOISearch in Google Scholar
  34. 34. M. Trotta, F. Debernardi and O. Caputo, Preparation of solid lipid nanoparticles by solvent emulsification-diffusion technique,(2003) 153-160; DOI: 10.1016/S0378-5173(03)00135-2.
    Open DOISearch in Google Scholar
  35. 35. L. Battaglia, M. Trotta, M. M. E. G. P. A. Solid lipid nanoparticles formed by solvent-in-eater emulsion-diffusion technique,(2009) 394-402.
    Search in Google Scholar
  36. 36. H. Yuan, L. F. Huang, Y. Z. Du, X. Y. Ying, J. You, F. Q. Hu and S. Zeng, Solid lipid nanoparticles prepared by solvent diffusion method in nanoreactor system,(2008) 132-137; DOI: 10.1016/j.colsurfb.2007.07.015.
    Open DOISearch in Google Scholar
  37. 37. J. Jaiswal, S. K. Gupta and J. Kreuter, Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification-solvent evaporation process,(2004) 169-178; DOI: 10.1016/j.jconrel.2004.01.017.
    Open DOISearch in Google Scholar
  38. 38. B. Sjostrom and B. Bergenstahl, Preparation of submicron drug particles in lecithin stabilizedemulsions I. Model studies of the precipitation of cholesteryl acetate,(1992) 53-62; DOI: 10.1016/0378-5173(92)90303-J.
    Open DOISearch in Google Scholar
  39. 39. K. Okuyama, M. Abdullah, I. W. Lenggoro and F. Iskandar, Preparation of functional nanostructured particles by spray drying,(2006) 587-611; DOI: 10.1163/156855206778917733.
    Open DOISearch in Google Scholar
  40. 40. K. Okuyama and I. W. Lenggoro, Preparation of nanoparticles via spray route,(2003) 537-547; DOI: 10.1016/S0009-2509(02)00578-X.
    Open DOISearch in Google Scholar
  41. 41. P. Luo and T. G. Nieh, Synthesis of ultrafine hydroxyapatite particles by spray dry method,(1995) 75-78; DOI: 10.1016/0928-4931(95)00089-5.
    Open DOISearch in Google Scholar
  42. 42. C. Freitas and R. H. Müller, Spray-drying of solid lipid nanoparticles (SLNTM),(1998) 145-151; DOI: 10.1016/S0939-6411(97)00172-0.
    Open DOISearch in Google Scholar
  43. 43. P. Tewa-Tange, S. Briancon and H. Fessi, Preparation of redispersible dry nanocapsules by means of spray-drying: Development and characterisation,(2007) 124-135; DOI: 10.1016/j.ejps.2006.10.006.
    Open DOISearch in Google Scholar
  44. 44. P. M. Gosselin, R. Thibert, M. Preda and J. N. McMullen, Polymorphic properties of micronized carbamazepine produced by RESS,(2003) 225-233; DOI: 10.1016/S0378-5173(02)00649-X.
    Open DOISearch in Google Scholar
  45. 45. A. J. Thote and R. B. Gupta, Formation of nanoparticles of a hydrophilic drug using supercritical carbon dioxide and microencapsulation for sustained release,(2005) 85-90; DOI: 10.1016/j.nano.2004.12.001.
    Open DOISearch in Google Scholar
  46. 46. J. Vandervoort and A. Ludwig, Preparation and evaluation of drug loaded gelatin nanoparticles for topical ophthalmic use,(2004) 251-261; DOI: 10.1016/S0939-6411(03)00187-5.
    Open DOISearch in Google Scholar
  47. 47. R. Paliwal, S. Rai, B. Vaidya, K. Khatri, A. K. Goyal, N. Mishra, A. Mehta and S. P. Vyas, Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery,(2009) 184-191; DOI: 10.1016/j.nano.2008.08.003.
    Open DOISearch in Google Scholar
  48. 48. C. Olbrich and R. H. Müller, Enzymatic degradation of SLN - Effect of surfactant and surfactant mixtures,(1999) 31-39; DOI: 10.1016/S0378-5173(98)00404-9.
    Open DOISearch in Google Scholar
  49. 49. C. C. Chen, T. H. Tsai, Z. R. Huang and J. Y. Fang, Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: Physicochemical characterization and pharmacokinetics,(2010) 474-482; DOI: 10.1016/j.ejpb.2009.12.008.
    Open DOISearch in Google Scholar
  50. 50. S. Y. Xie, S. L. Wang, B. K. Zhao, C. Han, M. Wang and W. Z. Zhou, Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles,(2008) 199-204; DOI: 10.1016/j.colsurfb.2008.08.018.
    Open DOISearch in Google Scholar
  51. 51. R. Cavalli, O. Caputo, M. E. Carlotti, M. Trotta, C. Scarnecchia and M. R. Gasco, Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles,(1997) 47-54; DOI: 10.1016/S0378-5173(96)04822-3.
    Open DOISearch in Google Scholar
  52. 52. C. Schwarz, W. Mehnert, J. S. Lucks and R. H. Müller, Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterisation and sterilization,(1994) 83-96.
    Open DOISearch in Google Scholar
  53. 53. W. Abdelwahed, G. Degobert, S. Stainmesse and H. Fessi, Freeze-drying of nanoparticles: Formulation, process and storage considerations,(2006) 1688-1713; DOI: 10.1016/j.addr.2006.09.017.
    Open DOISearch in Google Scholar
  54. 54. S. D. Allison, Md. C. Molina and T. J. Anchordoquy, Stabilization of lipid/DNA complexes during the freezing step of the lyophilization process: the particle isolation hypothesis,(2000) 127-138; DOI: 10.1016/S0005-2736(00)00251-0.
    Open DOISearch in Google Scholar
  55. 55. J. H. Crowe, J. F. Carpenter and L. M. Crowe, The role of vitrification in anhydrobiosis,.(1998) 73-103; DOI: 10.1146/annurev.physiol.60.1.73.
    Open DOISearch in Google Scholar
  56. 56. K. Westesen, B. Siekmann and M. H. J. Koch, Investigations on the physical state of lipid nanoparticles by synchrotron radiation X-ray diffraction,(1993) 189-199; DOI: 10.1016/0378-5173(93)90177-H.
    Open DOISearch in Google Scholar
  57. 57. H. Bunjes, K. Westesen and M. H. J. Koch, Crystallization tendencies and polymorphic transitions in triglyceride nanoparticles,(1996) 159-173; DOI: 10.1016/0378-5173(95)04286-5.
    Open DOISearch in Google Scholar
  58. 58. A. Z. Muhlen, C. Schwarz and W. Mehnert, Solid lipid nanoparticles (SLN) for controlled drug delivery - Drug release and release mechanism,(1998) 149-155.
    Open DOISearch in Google Scholar
  59. 59. S. Chakraborty, D. Shukla, B. Mishra and S. Singh, Lipid - An emerging platform for oral delivery of drugs with poor bioavailability,(2009) 1-15; DOI: 10.1016/j.ejpb.2009.06.001.
    Open DOISearch in Google Scholar
  60. 60. A. Radomska-Soukharev, Stability of lipid excipients in solid lipid nanoparticles,(2007) 411-418; DOI: 10.1016/j.addr.2007.04.004.
    Open DOISearch in Google Scholar
  61. 61. B. Heurtault, P. Saulnier, B. Pech, J.-E. Proust and J. P. Benoit, Physico-chemical stability of colloidal lipid particles,(2003) 4283-4300; DOI: 10.1016/S0142-9612(03)00331-4.
    Open DOISearch in Google Scholar
  62. 62. B. Siekmann and K. Westesen, Thermoanalysis of recrystallization process of melt homogenised glyceride nanoparticles,(1994) 159-175.
    Open DOISearch in Google Scholar
  63. 63. C. Freitas and R. H. Müller, Effect of light and temperature on zeta potential and physical stability of solid lipid nanoparticle (SLNTM) dispersions,(1998) 221-229.
    Open DOISearch in Google Scholar
  64. 64. C. Freitas and R. H. Müller, Stability determination of solid lipid nanoparticles (SLN) in aqueous dispersion after addition of electrolyte,(1999) 59-71; DOI: 10.1080/026520499289310.
    Open DOISearch in Google Scholar
  65. 65. C. Freitas and R. H. Müller, Correlation between long term stability of solid lipid nanoparticles (SLNTM) and crystallinity of lipid phase,(1999) 125-132.
    Open DOISearch in Google Scholar
  66. 66. K. Westesen and B. Siekmann, Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles,(1997) 35-45; DOI: 10.1016/S0378-5173(97)04890-4.
    Open DOISearch in Google Scholar
  67. 67. R. H. Müller and S. Heinemann, Fat emulsions for parenteral nutrition. III. Lipofundin MCT/LCT regimens for total parenteral nutrition (TPN) with low electrolyte load,(1994) 175-189; DOI: 10.1016/0378-5173(94)90213-5.
    Open DOISearch in Google Scholar
  68. 68. C. Freitas, J. Lucks and R. H. Müller, Effect of storage conditions on long-term stability of »solid lipid nanoparticles« (SLN) in aqueous dispersion,(1994) 117-194; DOI: 10.1016/0928-0987(94)90411-1.
    Open DOISearch in Google Scholar
  69. 69. B. Borgstrom, Importance of phospholipids, pancreatic phospholipase A2, and fatty acid for the digestion of dietary fat:experiments with the porcine enzymes,(1980) 954-962.
    Search in Google Scholar
  70. 70. R. O. Scow and T. Olivecrona, Effect of albumin on products formed from chylomicron triacylglycerol by lipoprotein lipase in vitro,(1977) 472-486; DOI: 10.1016/0005-2760(77)90217-X.
    Open DOISearch in Google Scholar
  71. 71. R. Pandey, S. Sharma and G. K. Khuller, Oral solid lipid nanoparticle-based antitubercular chemotherapy,(2005) 415-420, DOI: 10.1016/j.tube.2005.08.009.
    Open DOISearch in Google Scholar
  72. 72. N. Zhang, Q. Ping, G. Huang, W. Xua, Y. Cheng and X. Han, Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin,(2006) 153-159; DOI: 10.1016/j.ijpharm.2006.07.026.
    Open DOISearch in Google Scholar
  73. 73. M. D. Joshi and R. H. Müller, Lipid nanoparticles for parenteral delivery of actives,(2009) 161-172; DOI: 10.1016/j.ejpb.2008.09.003.
    Open DOISearch in Google Scholar
  74. 74. S. A. Wissing, O. Kayser and R. H. Müller, Solid lipid nanoparticles for parenteral drug delivery,.(2004) 1257-1272; DOI: 10.1016/j.addr.2003.12.002.
    Open DOISearch in Google Scholar
  75. 75. A. Fundarò, O, R. Cavalli, A. Bargoni, D. Vighetto, G. P. Zara and M. R. Gasco, Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue Distribution afteradministration to rats,(2000) 337-343; DOI: 10.1006/phrs.2000.0695.
    Open DOISearch in Google Scholar
  76. 76. S. C. Yang, L. F. Lu, Y. Cai, J. B. Zhu, B. W. Liang and C. Z. Yanga, Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain,(1999) 299-307; DOI: 10.1016/S0168-3659(99)00007-3.
    Open DOISearch in Google Scholar
  77. 77. L. H. Reddy, R. K. Sharma, K. Chuttani, A. K. Mishra and R. S. R. Murthy, Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton’s lymphoma tumor bearing mice,(2005) 185-198; DOI: 10.1016/j.jconrel.2005.02.028.
    Open DOISearch in Google Scholar
  78. 78. M. Schafer-Korting, W. Mehnert and H. C. Korting, Lipid nanoparticles for improved topical application of drugs for skin diseases,.(2007) 427-443; DOI: 10.1016/j.addr.2007.04.006.
    Open DOISearch in Google Scholar
  79. 79. V. Jenning, M. Schafer-Korting and S. Gohla, Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties,(2000) 115-126; DOI: 10.1016/S0168-3659(99)00007-3.
    Open DOISearch in Google Scholar
  80. 80. P. V. Pople and K. K. Singh, Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A,(2006) E1-E7; DOI: 10.1208/pt070491.
    Open DOISearch in Google Scholar
  81. 81. S. K. Jain, M. K. Chourasia, R. Masuriha, V. Soni, A. Jain, Nitin K. Jain and Y. Gupta, Solid lipid nanoparticles bearing flurbiprofen for transdermal delivery,(2005) 207-215; DOI: 10.1080/10717540590952591.
    Open DOISearch in Google Scholar
  82. 82. A. J. Almeida and E. Souto, Solid lipid nanoparticles as a drug delivery system for peptides and proteins,.(2007) 478-490; DOI: 10.1016/j.addr.2007.04.007.
    Open DOISearch in Google Scholar
  83. 83. J. Liu, T. Gong, H. Fu, C. Wang, X. Wang, Q. Chena, Q. Zhang, Q. Hea and Z. Zhang, Solid lipid nanoparticles for pulmonary delivery of insulin,(2008) 333-344; DOI: 10.1016/j.ijpharm.2008.01.008.
    Open DOISearch in Google Scholar
  84. 84. J. Araujo, E. Gonzalez, M. A. Egea, M. L. Garcia and E. B. Souto, Nanomedicines for ocular NSAIDs: safety on drug delivery,(2009) 394-401; DOI: 10.1016/j.nano.2009.02.003.
    Open DOISearch in Google Scholar
  85. 85. M. I. Alam, S. Beg, A. Samad, S. Baboota, K. Kohli, J. Ali, A. Ahuja and M. Akbar, Strategy for effective brain drug delivery.(2010) 385-403; DOI: 10.1016/j.ejps.2010.05.003.
    Open DOISearch in Google Scholar
  86. 86. I. P. Kaur, R. Bhandari, S. Bhandari and V. Kakkar, Potential of solid lipid nanoparticles in brain targeting,(2008) 97-100; DOI: 10.1016/j.jconrel.2007.12.018.
    Open DOISearch in Google Scholar
  87. 87. A. Mistry, S. Stolnik and L. Illum, Nanoparticles for direct nose-to-brain delivery of drugs,.(2009) 146-157; DOI: 10.1016/j.ijpharm.2009.06.019.
    Open DOISearch in Google Scholar
  88. 88. I. Brasnjevic, H. W. M. Steinbusch, C. Schmitz and P. Martinez-Martinez, Delivery of peptide and protein drugs over the blood-brain barrier,(2009) 212-251; DOI: 10.1016/j.pneurobio.2008.12.002.
    Open DOISearch in Google Scholar
  89. 89. F. Chellat, Y. Merhi, A. Moreau and L. H. Yahia, Therapeutic potential of nanoparticulate systems for macrophage targeting,(2005) 7260-7275; DOI: 10.1016/j.biomaterials.2005.05.044.
    Open DOISearch in Google Scholar
  90. 90. H. Chen, X. Chang, D. Du, W. Liu, J. Liu, T. Weng, Y. Yang, H. Xu and X. Yang, Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting,(2006) 296-306; DOI: 10.1016/j.jconrel.2005.09.052.
    Open DOISearch in Google Scholar
  91. 91. R. H. Müller, S. Maaben, H. Weyhers, F. Specht and J. S. Lucks, Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles,.(1996) 85-94; DOI: 10.1016/0378-5173(96)04539-5.
    Open DOISearch in Google Scholar
  92. 92. D. M. Radolfi, P. D. Marcato, R. A. Silva, G. Z. Justo and N. Duran, In vitro cytotoxicity assay of solid lipid nanoparticles in epithelial and dermal cells,(2011) 1-4; DOI: 10.1088/1742-6596/304/1/012032.
    Open DOISearch in Google Scholar
  93. 93. H. Yuan, J. Miao, Y. Z. Du, J. You, F. Q. Hu and S. Zeng, Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells,(2008) 137-145; DOI: 10.1016/j.ijpharm.2007.07.012.
    Open DOISearch in Google Scholar
  94. 94. J. C. Olivier, Drug transport to brain with targeted nanoparticles,( 2005) 108-119; DOI: 10.1602/neurorx.2.1.108.
    Open DOISearch in Google Scholar
  95. 95. T. R. Pisanic II, J. D. Blackwell, V. I. Shubayev, R. R. Fiñones and S. Jin, Nanotoxicity of iron oxide nanoparticle internalization in growing neurons,(2007) 2572-2581; DOI: 10.1016/j.biomaterials.2007.01.043.
    Open DOISearch in Google Scholar
  96. 96. H. C. Fischer, W. C. Chan, Nanotoxicity: the growing need for in vivo study,.(2007) 565-571; DOI: 10.1016/j.copbio.2007.11.008.
    Open DOISearch in Google Scholar
  97. 97. Y. L. Hu and J. Q. Gao, Potential neurotoxicity of nanoparticles,.(2010) 115-121; DOI: 10.1016/j.ijpharm.2010.04.026.
    Open DOISearch in Google Scholar
  98. 98. K. Jores, W. Mehnert, M. Drechsler, H. Bunjes, C. Johann and K. Mäder, Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy,(2004) 217-227; DOI: 10.1016/j.jconrel.2003.11.012.
    Open DOISearch in Google Scholar
  99. 99. S. Chakraborty, B. Sahoo, I. Teraoka and R. A. Gross, Solution properties of starch nanoparticles in water and DMSO as studied by dynamic light scattering,.(2005) 475-481; DOI: 10.1016/j.carbpol.2005.03.011.
    Open DOISearch in Google Scholar
  100. 100. B. G. Zanetti-Ramos, M. B. Fritzen-Garcia, C. S. de Oliveira, A. A. Pasa, V. Soldi, R. Borsali and T. B. Creczynski-Pasa, Dynamic light scattering and atomic force microscopy techniques for size determination of polyurethane nanoparticles,.(2009) 638-640; DOI: 10.1016/j.msec.2008.10.040.
    Open DOISearch in Google Scholar
  101. 101. L. Dulog and T. Schauer, Field flow fractionation for particle size determination,(1996) 25-31; DOI: 10.1016/0300-9440(95)00584-6.
    Open DOISearch in Google Scholar
  102. 102. A. S. Dukhin, P. J. Goetz, X. Fang and P. Somasundaran, Monitoring nanoparticles in the presence of larger particles in liquids using acoustics and electron microscopy,(2010) 18-25; DOI: 10.1016/j.jcis.2009.07.001.
    Open DOISearch in Google Scholar
  103. 103. V. Jenning, K. Mäder and S. H. Gohla, Solid lipid nanoparticles (SLN™) based on binary mixtures of liquid and solid lipids: 1H-NMR study,.(2000) 15-21; DOI: 10.1016/S0378-5173(00)00462-2.
    Open DOISearch in Google Scholar
  104. 104. A. Dubes, H. Parrot-Lopez, W. Abdelwahed, G. Degobert, H. Fessi, P. Shahgaldian and A. W. Coleman, Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins,.(2003) 279-282; DOI: 10.1016/S0939-6411(03)00020-1.
    Open DOISearch in Google Scholar
  105. 105. M. Albrecht, V. Janke, S. Sievers, U. Siegner, D. Schulerb and U. Heyen, Scanning force microscopy study of biogenic nanoparticles for medical applications,(2005) 269-271; DOI: 10.1016/j.jmmm.2004.11.206.
    Open DOISearch in Google Scholar
  106. 106. N. Škalko, J. Bouwstra, F. Spies, M. Stuart, P. M. Frederik and G. Gregoriadis, Morphological observations on liposomes bearing covalently bound protein: Studies with freeze-fracture and cryo electron microscopy and small angle X-ray scattering techniques,(1998) 151-160; DOI: 10.1016/S0005-2736(97)00256-3.
    Open DOISearch in Google Scholar
  107. 107. K. Fowler, L. A. Bottomley and H. Schreier, Surface topography of phospholipid bilayer and vesicles (liposomes) by scanning tunnelling microscopy (STM),(1992) 283-292; DOI: 10.1016/0168-3659(92)90103-X.
    Open DOISearch in Google Scholar
  108. 108. O. Robach, C. Quiros, S. M. Valvidares, C. J. Walker and S. Ferrer, Structure and Pt magnetism of FePt nanoparticles investigated with X-ray diffraction,(2003) 202-208; DOI: 10.1016/S0304-8853(03)00205-1.
    Open DOISearch in Google Scholar
  109. 109. M. A. Schubert, B. C. Schicke and C. C. Muller-Goymann, Thermal analysis of the crystallization and melting behaviour of lipid matrices and lipid nanoparticles containing high amounts of lecithin,(2005) 242-254; DOI: 10.1016/j.ijpharm.2005.04.014.
    Open DOISearch in Google Scholar
  110. 110. S. A. Wissing and R. H. Müller, Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration,(2002) 225-233; DOI: 10.1016/S0168-3659(02)00056-1.
    Open DOISearch in Google Scholar
  111. 111. C. Song and S. Liu, A new healthy sunscreen system for human: Solid lipid nannoparticles as carrier for 3,4,5-trimethoxybenzoylchitin and the improvement by adding vitamin E(2005) 116-119; DOI: 10.1016/j.ijbiomac.2005.05.003.
    Open DOISearch in Google Scholar
  112. 112. J. Pardeike, A. Hommoss and R. H. Müller, Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products,.(2009) 170-184; DOI: 10.1016/j.ijpharm.2008.10.003.
    Open DOISearch in Google Scholar
  113. 113. S. A. Wissing and R. H. Müller, Cosmetic applications for solid lipid nanoparticles (SLN),.(2003) 65-68; DOI: 10.1016/S0378-5173(02)00684-1.
    Open DOISearch in Google Scholar
  114. 114. K. A. Shah, A. A. Date, M. D. Joshi and V. B. Patravale, Solid lipid nanoparticles (SLN) of tretinoin: Potential in topical delivery,.(2007) 163-171; DOI: 10.1016/j.ijpharm.2007.05.061.
    Open DOISearch in Google Scholar
  115. 115. J. Liu, W. Hu, H. Chen, Q. Ni, H. Xu and X. Yang, Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery.(2007) 191-195; DOI: 10.1016/j.ijpharm.2006.08.007.
    Open DOISearch in Google Scholar
  116. 116. M. S. Korting, W. Mehnert and H. C. Korting, Lipid nanoparticles for improved topical application of drugs for skin diseases,(2007) 427-443; DOI: 10.1016/j.addr.2007.04.006.
    Open DOISearch in Google Scholar
  117. 117. A. del Pozo-Rodrigueza, D. Delgadoa, M. A. Solinis, J. L. Pedraza, E. Echevarria, J. M. Rodriguez and A. R. Gascona, Solid lipid nanoparticles as potential tools for gene therapy: In vivo protein expression after intravenous administration,.(2010) 157-162; DOI: 10.1016/j.ijpharm.2009.10.020.
    Open DOISearch in Google Scholar
  118. 118. S. H. Choi, S. E. Jin, M. K. Lee, S. J. Lim, J. S. Park, B. G. Kim, W. S. Ahn and C. K. Kim, Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells,.(2008) 545-554; DOI: 10.1016/j.ejpb.2007.07.011.
    Open DOISearch in Google Scholar
  119. 119. N. Pedersen, S. Hansen, A. V. Heydenreich, H. G. Kristensen and H. S. Poulsen, Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands,.(2006) 155-162; DOI: 10.1016/j.ejpb.2005.09.003.
    Open DOISearch in Google Scholar
  120. 120. H. L. Wong, R. Bendayan, A. M. Rauth, Y. Li and X. Y. Wu, Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles,(2007) 491-504; DOI: 10.1016/j.addr.2007.04.008.
    Open DOISearch in Google Scholar
  121. 121. H. L. Wong, R. Bendayan, A. M. Rauth and X. Y. Wu, Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new Polymer-Lipid Hybrid Nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer,(2006) 275-284; DOI: 10.1016/j.jconrel.2006.09.007.
    Open DOISearch in Google Scholar
  122. 122. R. K. Subedi, K. W. Kang and H. K. Choi, Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin,(2009) 508-513; DOI: 10.1016/j.ejps.2009.04.008.
    Open DOISearch in Google Scholar
  123. 123. B. Lu, S. B. Xiong, H. Yang, X. D. Yin and R. B. Chao, Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases,.(2006) 86-95; DOI: 10.1016/j.ejps.2006.01.001.
    Open DOISearch in Google Scholar
  124. 124. N. Csaba, M. Garcia-Fuentes and M. J. Alonso, Nanoparticles for nasal vaccination,(2009) 140-157; DOI: 10.1016/j.addr.2008.09.005.
    Open DOISearch in Google Scholar
  125. 125. S. M. Moghimi and J. Szebeni, Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties,(2003) 463-478; DOI: 10.1016/S0163-7827(03)00033-X.
    Open DOISearch in Google Scholar
  126. 126. Y. Wang and W. Wu, In situ evading of phagocytic uptake of stealth solid lipid nanoparticles by mouse peritoneal macrophages,(2006) 189-192; DOI: 10.1080/10717540-500-315330.
    Search in Google Scholar
  127. 127. M. R. Gasco, Lipid nanoparticles: perspectives and challenges,(2007) 377-378; DOI: 10.1016/j.addr.2007.05.004.
    Open DOISearch in Google Scholar
  128. 128. A. J. Domb, Long acting injectable oxytetracycline-liposphere formulations,.(1995) 271-278; DOI: 10.1016/0378-5173(95)00098-4.
    Open DOISearch in Google Scholar
  129. 129. C. Schwarz and W. Mehnert, Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN),.(1997) 171-179; DOI: 10.1016/S0378-5173(97)00222-6.
    Open DOISearch in Google Scholar
  130. 130. K. Westesen, H. Bunjes and M. H. J. Koch, Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential,(1997) 223-236; DOI: 10.1016/S0168-3659(97)00046-1.
    Open DOISearch in Google Scholar
  131. 131. K. Westesen, B. Siekmann and M. H. J. Koch, Investigations on the physical state of lipid nanoparticles by synchrotron radiation X-ray diffraction,(1993) 189-199; DOI: 10.1016/0378-5173(93)90177-H.
    Open DOISearch in Google Scholar
  132. 132. A. J. Almeida, S. Runge and R. H. Müller, Peptide-loaded solid lipid nanoparticles (SLN): influence of production parameters,(1997) 255-265; DOI: 10.1016/S0378-5173(97)04885-0.
    Open DOISearch in Google Scholar
  133. 133. R. Cavalli, E. Peira, O. Caputo and M. R. Gasco, Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with a-cyclodextrins,(1999) 59-69.
    Open DOISearch in Google Scholar
  134. 134. H. Ali, A. B. Shirode, P. W. Sylvester and S. Nazzal, Preparation andantiproliferative effect of tocotrienol loaded lipid nanoparticles,(2010) 43-51; DOI: 10.1016/j.colsurfa.2009.10.020.
    Open DOISearch in Google Scholar
  135. 135. R. Cavalli, S. Morel, M. R. Gasco, P. Chetoni and M. F. Saettone, Preparation and evaluation in vitro of colloidal lipospheres containing pilocarpine as ion pair,(1995) 243-246; DOI: 10.1016/0378-5173(94)00339-7.
    Open DOISearch in Google Scholar
  136. 136. S. Morel, E. Terreno, E. Ugazio, S. Aime and M. R. Gasco, NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium(III) complexes,.(1998) 157-163; DOI: 10.1016/S0939-6411(97)00107-0.
    Open DOISearch in Google Scholar
  137. 137. M. R. Gasco, R. Cavalli and M. E. Carlotti, Timolol in lipospheres,(1992) 119-121.
    Search in Google Scholar
  138. 138. A. A. Attama and C. C. Müller-Goymann, Effect of beeswax modification on the lipid matrix and solid lipid nanoparticle crystallinity,(2008) 189-195; DOI: 10.1016/j.colsurfa.2007.07.035.
    Open DOISearch in Google Scholar
  139. 139. S. Kheradmandia, E. Vasheghani-Farahani, M. Nosrati and F. Atyabi, Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax,(2010) 753-759; DOI: 10.1016/j.nano.2010.06.003.
    Open DOISearch in Google Scholar
  140. 140. B. D. Kim, K. Na and H. K. Choi, Preparation and characterization of solid lipid nanoparticles (SLN) made of cacao butter and curdlan,.(2005) 199-205; DOI: 10.1016/j.ejps.2004.10.008.
    Open DOISearch in Google Scholar
  141. 141. C. Bocca, O. Caputo, R. Cavalli, L. Gabrial, A. Miglietta and M. R. Gasco, Phagocytic uptake of fluorescent stealth and non-stealth solid lipid nanoparticles,(1998) 185-193; DOI: 10.1016/S0378-5173(98)00282-8.
    Open DOISearch in Google Scholar
  142. 142. T. M. Goppert and R. H. Müller, Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN),(2005) 361-372; DOI: 10.1016/j.ejpb.2005.02.006.
    Open DOISearch in Google Scholar
  143. 143. H. M. Redhead, S. S. Davis and L. Illum, Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908:characterisation andevaluation,(2001) 353-363.
    Search in Google Scholar
  144. 144. C. Olbrich, O. Kayser and R. H. Müller, Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN) - effect of surfactants, storage time and crystallinity,(2002) 119-128; DOI: 10.1016/S0378-5173(02)00035-2.
    Open DOISearch in Google Scholar
  145. 145. C. C. Shen, W. L. Tseng and M. M. Hsieh, Selective enrichment of aminothiols using polysorbate 20-capped gold nanoparticles followed by capillary electrophoresis with laser-induced fluorescence,(2009) 288-293; DOI: 10.1016/j.chroma.2008.11.044.
    Open DOISearch in Google Scholar
  146. 146. L. D. Marzio, C. Marianecci, M. Petrone, F. Renaldi and M. Carafa, Novel pH-sensitive non-ionic surfactant vesicles: comparison between Tween 21 and Tween 20,(2011) 18-24; DOI: 10.1016/j.colsurfb.2010.08.004.
    Open DOISearch in Google Scholar
  147. 147. L. H. Reddy, K. Vivek, N. Bakshi and R. S. R. Murthy, Tamoxifen citrate loaded solid lipid nanoparticles (SLN™): Preparation, characterization, in vitro drug release, and pharmacokinetic evaluation,(2006) 167-177; 2006, DOI: 10.1080/10837450600561265.
    Open DOISearch in Google Scholar
  148. 148. F. Q. Hu, H. Yuan, H. H. Zhang and M. Fang, Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization,.(2002) 121-128; DOI: 10.1016/S0378-5173(02)00081-9.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10007-012-0040-z | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English, Croatian, Slovenian
Page range: 433 - 472
Published on: Jan 15, 2013
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
colloidal drug carrier,
solid lipid nanoparticles (SLN),
stability,
targeting efficiency,
cytotoxicity,
stealthing of SLN
Related subjects:
Pharmacy,
Pharmacy, other

© 2013 Chandrakantsing Pardeshi, Pravin Rajput, Veena Belgamwar, Avinash Tekade, Ganesh Patil, Kapil Chaudhary, Abhijeet Sonje, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.

Volume 62 (2012): Issue 4 (December 2012)
Next article